B cells and osteoblast and osteoclast development

Immunological Reviews

Volumn 208, Issue , 2005, Pages 141-153

  Horowitz, Mark C ^a   Bothwell, Alfred L M ^a   Hesslein, David G T ^b   Pflugh, David L ^a   Schatz, David G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HELIX LOOP HELIX PROTEIN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADIPOCYTE; ALBERS SCHOENBERG DISEASE; B LYMPHOCYTE; BONE CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL MATURATION; GENE MUTATION; MACROPHAGE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; WAARDENBURG SYNDROME;

EID: 28544447532     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00328.x     Document Type: Review

References (133)

1. Udagawa N, et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 1989;125:1805-1813.
2. Lacey DL, et al. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
3. Yasuda H, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-3602.
4. Anderson MA, et al. A homologue of the TNF receptor and its ligand enchance T-cell growth and dendritic-cell function. Nature 1998;390:175-179.
5. Wong BR, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells. J Biol Chem 1997;272:25190-25194.
6. Kurihara N, Chenu C, Civin CI, Roodman GD. Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term marrow cultures. Endocrinology 1990;126:2733-2741.
7. Roodman GD. Advances in bone biology: the osteoclast. Endocr Rev 1996;17:308-332.
8. Hattersley G, Kerby JA, Chambers TJ. Generation of osteoclast precursors in multilineage hematopoietic colonies. Endocrinology 1991;128:259-262.
9. Lee MY, Eyre DR, Osborne WR. Isolation of murine osteoclast colony-stimulating factor. Proc Natl Acad Sci USA 1991;88:8500-8504.
10. Horowitz MC, Kacena MA, Lorenzo JA. Genetics and mutation affecting osteoclast development and function. In: Farach-Carson MC, Rubin J, Bronner F, eds. Bone Resorption. London: Springer-Verlag, 2004; 91-107.
11. Friedenstein AJ. Osteogenic stem cells in the bone marrow. In: Jeersche JNM, Kanis JA, eds. Bone and Mineral Research. London: Elsevier Science Publishers BV, 1990: 243-270.
12. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-650.
13. Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 1997;276:71-74.
14. Owen ME. The marrow stromal cell system. In: Beresford JN, Owen ME, eds. Marrow Stromal Stem Cells in Culture. Cambridge: Cambridge University Press, 1998:88-110.
15. Komori T, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-764.
16. Lum L, et al. Evidence for a role of a tumor necrosis factor-α (TNF-α)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survivial. J Biol Chem 1999;274:13613-13618.
17. Quinn JMW, Elliott J, Gillespie MT, Martin TJ. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998;139:4424-4427.
18. Yao G-Q, et al. The cell-surface form of colony-stimulating factor-1 (CSF-1) is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. J Biol Chem 1998;273:4119-4128.
19. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1α and tumor necrosis factor-α, but not interleukin-6 stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999;25:255-259.
20. 3 or parathyroid hormones. J Biol Chem 1999;274:19301-19308.
21. Kobayashi KN, et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/ RANKLRANK interaction. J Exp Med 2000;191:275-286.
22. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J Biol Chem 2000;275:4858-4864.
23. Kim N, et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 2005;202:589-595.
24. Taichman RS, Reilly MJ, Emerson SG. The hematopoietic microenvironment: osteoblasts and the hematopoietic microenvironment. Hematology 2000;4:421-426.
25. Zhang J, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425:836-841.
26. Calvi LM, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841-846.
27. Ghia P, Boekel E, Rolink AG, Melchers F. B-cell development: a comparison between mouse and man. Immunol Today 1998;19:480-485.
28. Hesslein DG, Schatz DG. Factors and forces controlling V(D)J recombination. Adv Immunol 2001;78:169-232.
29. Hardy RR, Carmack CE, Shinton SA. Resolution and characterization of pro-B and pre-B cell stages on normal mouse bone marrow. J Exp Med 1991;173:1213-1225.
30. Li YS, Hayakawa K, Hardy RR. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med 1993;178:951-960.
31. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001;19:595-621.
32. Li YS, Wasserman R, Hayakawa K, Hardy RR. Identification of the earliest B lineage stage in mouse marrow. Immunity 1996;5:527-553.
33. Melchers F, et al. The surrogate light chain in B cell development. Immunol Today 1993;14:60-68.
34. Rolink A, Haasner D, Melchers F, Anderson J. The surrogate light chain in mouse B-cell development. Int Rev Immunol 1996;13:341-356.
35. Ehlich A, Schaal S, Gu H, Kitamura D, Muller W, Rajewsky K. Immunology heavy and light chain genes rearrange independently at early stages of B cell development. Cell 1993;72:695-704.
36. Gong S, Nussenzweig M. Regulation of an early developmental checkpoint in the B cell pathway by Ig. Science 1996;272:411-414.
37. Nemazee D. Receptor editing in B cells. Adv Immunol 2000;74:89-126.
38. Peschon JJ, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994;180:1955-1960.
39. Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995;181:1519-1526.
40. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999;401:556-562.
41. Bain G, et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 1994;79:885-892.
42. Lin H, Grosschedl R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 1995;376:263-267.
43. Sigvardsson M, O'Riordan M, Grosschedl R. EBF and E47 collaborate to induce expression of the endogenoud immunoglobulin surrogate light chain genes. Immunity 1997;7:25-36.
44. Adams B, et al. Pax5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev 1992;6:1589-1607.
45. Walker DG. Control of bone resorption by hematopoietic tissue. J Exp Med 1975;142:651-663.
46. Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 1975;190:784-785.
47. Walker DG. Spleen cells transmit osteopetrosis in mice. Science 1975;190:785-787.
48. Flex R, Cecchini MG, Fleisch H. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 1990;127:2592-2594.
49. Yoshida H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-444.
50. Kodama H, et al. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony stimulating factor. J Exp Med 1991;173:269-272.
51. Lu L, Osmond DG. Regulation of cell survival during B lymphopoiesis in mouse bone marrow: enhanced pre-B-cell apoptosis in CSR-1-deficient op/op mutant mice. Exp Hematol 2001;29:596-601.
52. Tagaya H, et al. Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice. Blood 2000;95:3363-3370.
53. Begg SK, et al. Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med 1993;177:237-242.
54. Kong Y-Y, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-323.
55. Dougall WC, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13:2412-2424.
56. Lomaga MA, et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999;13:1015-1024.
57. Wong BR, Josien R, Lee SY, Vologodskaia RM, Steinman RM, Choi Y. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor. J Biol Chem 1998;273:28355-28359.
58. Lacey DL, et al. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol 2000;157:435-448.
59. Emery JG, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 1998;273:14363-14367.
60. Sedger LM, et al. Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. Eur J Immunol 2002;32:2246-2254.
61. Bucay N, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-1268.
62. Mizuno A, et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/ Osteoprotegerin. Biochem Biophys Res Commun 1998;247:610-615.
63. Yun TJ, et al. Osteoprtegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol 2001;166:1482-1491.
64. Shultz LD, et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphates (Hcph) gene. Cell 1993;73:1445-1454.
65. Umeda S, et al. Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. Am J Pathol 1999;155:223-233.
66. Kuro-o M, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51.
67. Kawaguchi H, et al. Independent impairment of osteoblast and osteoclast differentiation in klodio mouse exhibiting low-turnover osteopenia. J Clin Invest 1999;104:229-237.
68. Manabe N, et al. Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 2001;167:2625-2631.
69. Jacquin C, Lee S, Lorenzo JA, Aquila HL. Identification of multiple osteoclast precursor populations by flow cytometry in murine bone marrow [Abstract]. J Bone Miner Res 2004.
70. Miyaura C, et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: Similarity to estrogen deficiency. Proc Nat Acad Sci USA 1997;94:9360-9365.
71. Valenzona HO, Pointer R, Ceredig R, Osmound DG. Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: Precursor B cell dynamics, microenvironmental organization and osteolysis. Exp Hematol 1996;24:1521-1529.
72. Lee S-K, et al. Interleukin-7 is a direct inhibitor of in vitro osteodastogenesis. Endocrinology 2003;144:3524-3531.
73. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 1993;260:626-627.
74. Masuzawa T, et al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 1994;94:1090-1097.
75. Medina KL, Smithson G, Kincade PW. Suppression of B lymphopoiesis during normal pregnancy. J Exp Med 1993;178:1507-1515.
76. Smithson G, Medina K, Ponting I, Kincade PW. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 1995;155:3409-3417.
77. Katavic V, et al. The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone 2003;32:581-590.
78. + cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 2001;16:2215-2221.
79. DeKoter RP, Walsh JC, Singh H. PL1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J 1998;17:4456-4468.
80. Anderson KL, et al. Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood 1998;92:1576-1585.
81. Tondravi MM, et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 1997;386:81-84.
82. DeKoter RP, Lee H-J, Singh H. PU1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 2002;16:297-309.
83. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 2000;288:1439-1441.
84. Luchin A, et al. Genetic and physical interactions between microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem 2001;276:36703-36710.
85. Steingrimsson E, et al. Molecular basis of mouse microphthalmia mi mutations helps explain their developmental and phenotypic consequences. Nat Genet 1994;8:256-263.
86. Moore KJ. Insight into the microphthalmia gene. Trends Genet 1995;11:442-448.
87. Thesingh CW, Scherft JP. Fusion disability of embryonic osteoclast precursor cells and macrophages in the microphthalmic osteopetrotic mouse. Bone 1985;6:43-52.
88. Glowacki J, Cox KA, Wilcon S. Impaired osteoclast differentiation in subcutaneous implants of bone particles in osteopetrotic mutants. Bone Miner 1989;5:271-278.
89. Luchin A, et al. The microphthalmia transcription factor regulates expression of the tartrate-resident acid phosphatase gene during terminal differentiation of osteoclasts. J Bone Miner Res 2000;15:451-460.
90. Georgopoulos K, et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994;79:143-156.
91. Nichogiannopoulou A, Trevisan M, Neben S, Friedrich C, Georgopoulos K. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med 1999;190: 1201-1214.
92. Sitnicka E, et al. Complementary signaling through flt3 and interleukin-7 receptor is indispensable for fetal and adult B cell genesis. J Exp Med 2003;198:1495-1506.
93. Vobhenrich CAJ, Cumano A, Muller W, Di Santo JP, Vieira P. Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development. Nat Immunol 2003;4:773-779.
94. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 1989;56:777-783.
95. Murre C, et al. Structure and function of helix-loop-helix proteins. Biochem Biophys Acta 1994;1218:129-135.
96. Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell 1994;79:875-884.
97. O'Riordan M, Grosschedl R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 1999;11:21-31.
98. Smith EM, Gisler R, Sigvardsson M. Cloning and characterization of a promoter flanking the Early B Cell Factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression. J Immunol 2002;169:261-270.
99. Seet CS, Brumbaugh RL, Kee BL. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J Exp Med 2004;199:1689-1700.
100. Saiki Y, Yamazaki Y, Yoshida M, Katoh O, Nakamura T. Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoietic progenitors and down-regulated during myeloid differentiation of HL60 cells. Genomics 2000;70:387-391.
101. Liu P, et al. Bell la is essential for normal lymphoid development. Nat Immunol 2003;4:525-532.
102. Campos-Ortega JA. The genetics of the Drosophila achaete-scute gene complex: a historical appraisal. Int J Dev Biol 1998;42:291-297.
103. Dambly-Chaudiere C, Vervoort M. The bHLH genes in neural development. Int J Dev Biol 1998;42:269-273.
104. Wang MM, Reed RR. Molecular cloning of the olfactory neuronal transcription factor Olf-1 by genetic selection in yeast. Nature 1993;364:121-126.
105. Hagman J, Belanger C, Travis A, Turck CW, Grosschedl R. Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes Dev 1993;7:760-773.
106. Garel S, Marin F, Mattei MG, Vesque C, Vincent A, Charnay P. Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system. Dev Dyn 1997;210:191-205.
107. Wang SS, Tsai RYL, Reed RR. The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development. J Neurosci 1997;17:4149-4158.
108. Wang SS, Betz AG, Reed RR. Cloning of a novel Olf-1/DBF-like gene, O/E-4, by degeneration oligo-based direct selection. Mol Cell Neurosci 2002;20:404-414.
109. Crozatier M, Valle D, Dubois L, Ibnsouda S, Vincent A. Collier, a novel regulator of Drosophila head development, is expressed in a single domain. Curr Biol 1996;6:707-718.
110. Frasch M. Controls in patterning and diversification of somatic muscles during Drosophila embryogenesis. Curr Opin Genet Dev 1999;9:522-529.
111. Hata A, Seoane J, Langna G, Montalvo E, Hemmati-Brivanlou A, Massague J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 2000;100:229-240.
112. Akerblad P, Lind U, Liberg D, Bamberg K, Sigvardsson M. Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation. Mol Cell Biol 2002;22:8015-8025.
113. Dowell P, Cooke DW. Olf-1/early B cell factor is a regulator of gult4 gene expression in 3T3-L1 adipocytes. J Biol Chem 2002;277:1712-1718.
114. Zhang Z, Cotta CV, Stephan RP, deGuzman CG, Klug CA. Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage. EMBO J 2003;22:4759-4769.
115. Hesslein DGT, et al. The transcription factor EBF-1 regulates osteoblast and adipocytes development [Abstract]. J Bone Miner Res 2005;20:547.
116. Kieslinger M, Folberth S, Consalez G, Grosschedl R. Regulation of B lymphopoiesis by EBF proteins [Abstract]. B Cell Development, Function & Disease, Keystone Symposia 2005, 22.
117. Wang SS, Lewcock JW, Feinstein P, Mombaerts P, Reed RR. Genetic disruptions of O/E2 and O/E3 genes reveal involvement in olfactory receptor neuron projection. Development 2004;131:1377-1388.
118. Bopp D, Burn M, Baumgartner S, Frigerio G, Noll M. Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosphila. Cell 1986;47:1033-1040.
119. Walther C, et al. Pax: a murine multigene family of paired box-containing genes. Genomics 1991;11:424-434.
120. Burri M, Tromvoulis Y, Bopp D, Frigerio G, Noll M. Conservation of the paired domain in metazoans and its structure in three isolated human genes. EMBO J 1989;8:1183-1190.
121. Baumgartner M, Bopp D, Burri M, Noll M. Structure of two genes at the gooseberry locus related to the paired gene and their spatial expression during Drosophila embryogenesis. Genes Dev 1987;1: 1247-1267.
122. Balling R, Deutsch U, Gruss P. Undulated, a mutation affecting the development of the mouse skeleton, has a point mutation in the paired box of Pax1. Cell 1988;55:531-535.
123. Epstein DJ, Vekemans M, Gros P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax3. Cell 1991;57:767-774.
124. Hill ER, et al. Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 1991;354:522-525.
125. Baldwin CT, Hoth CF, Amos JA, da-Silva EO, Milunsky A. An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature 1992;355:637-638.
126. Ton CCT, et al. Positional cloning and characterization of a paired-box-and homebox-containing gene from the anirida region. Cell 1991;57:1059-1074.
127. Urbánek P, Wang Z-Q, Fetka I, Wagner EF, Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/ BSAP. Cell 1994;79:901-912.
128. Arai F, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor KB (RANK) receptors. J Exp Med 1999;12:1741-1754.
129. Horowitz MC, et al. Pax5 deficient mice exhibit early onset osteopenia with increased osteoclast progenitors. J Immunol 2004;173:6583-6591.
130. Cotta CV, Zhang Z, Kim H-G, Klug CA. Pax5 determines B- verses T-cell fate and does not block early myeloid development. Blood 2003;101:4342-4346.
131. Tagoh H, et al. Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible. EMBO J 2004;23:4275-4285.
132. Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004;117:663-676.
133. Montecino-Rodriguez E, Leathers H, Dorshkind K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nat Immunol 2001;2:83-88.